Quince Therapeutics, Inc. (QNCX)

1.37 +0.03 (+2.24%) USD  |  NASDAQ  |  Apr 17, 16:00
1.29 -0.08 (-5.84%) After-Hours: 20:00
More

Quince Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for QNCX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
Ocular Therapeutix, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade
Acurx Pharmaceuticals, Inc. --